medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2018, Number 5

<< Back Next >>

Acta Pediatr Mex 2018; 39 (5)

Use of erythrocyte package in neonatology: a qualitative review

Jaramillo-Jaramillo LI, Villegas-Alzate JD, Ruiz-Mejía C, Álvarez-Hernández LF, Martínez-Sánchez LM

Language: Spanish
References: 46
Page: 298-306
PDF size: 400.90 Kb.


ABSTRACT

Background: Transfusion of blood products, especilly red blood cells, is one of the most common interventions in daily medical practice and in neonatal units the target population of this intervention is greater than that of other premature risks and with low birth weight.
Objective: This review will be to generate the most important aspects of the use of erythrocyte package in the neonatal population and the available evidence in this regard.
Description: Transfusions of blood products are multiple, especially in the neonatal population, among which include: necrotizing enterocolitis, retinopathy of prematurity, intraventricular hemorrhage, chronic lung disease, among others, so the decision to perform this procedure should be taken considering the indications and possible complications.
Conclusions: New protocols have been developed to minimize the risks associated with this procedure, among which the use of single-donor aliquots is highlighted, to reduce the complications of incompatibility.


REFERENCES

  1. Banerjee J, et al. Blood transfusion in preterm infants improves intestinal tissue oxygenation without alteration in blood flow. Vox Sang. 2016;111(4):1-10. https://doi. org/10.1111/vox.12436

  2. Heddle NM, et al. Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion. N Eng J Med. 2016;375(20):1937-45. DOI: 10.1056/NEJMoa1609014

  3. Finn D, Dorrian A, et al. Emergency uncross-matched blood transfusions in a tertiary neonatal unit. Acta Paed. 2016; 106:218-22. https://doi.org/10.1111/apa.13646

  4. Miller HD, et al. Assessment of Mesenteric Tissue Saturation, Oxygen Saturation, and Heart Rate Pre- and Post- Blood Transfusion in Very Low-Birth-Weight Infants Using Abdominal Site Near-Infrared Spectroscopy. Adv Neonatal Care. 2017;17(5):E3-E9. https://doi.org/10.1097/ ANC.0000000000000417

  5. Ministerio de Salud y Protección Social. Guía de práctica clínica basada en evidencia para el uso de componentes sanguíneos/hemocomponentes. Bogotá; 2017. Módulo 10. P 395-404.

  6. Oliveira E, Herdy V, Pereira D, Dallabela F, Vidal J, Linhares V. Nurses’ knowledge of blood transfusion in neonate. Rev Gaúcha Enferm. 2017;38(1):e63557. ttp://dx.doi. org/10.1590/1983-1447.2017.01.63557

  7. OJO. NO SE ENCONTRÓ Wang YC, Chan OW, Chou M, Hong P, Chu SM, Hsu JF, et al. Red Blood Cell Transfusion and Clinical Outcomes in Extremely Low Birth Weight Preterm Infants. Pediatr Neonatol. 2017; 58: 216-22.

  8. Saldaña-Casas O, De la Torre-Fernández A, Guzmán-García M, Blas-Mendiola C, Gómez-Gómez M, Saltigeral-Simental P. Transfusión de componentes sanguíneos en un hospital privado para niños. Rev Mex Pediatr. 2005; 72(2); 65-9.

  9. Arca G, Carbonell-Estrany X. López J, Figueras J, Fernández B, Blanco D, Closa R, Narbona E, et al. Anemia neonatal. En: Junta Directiva de la Sociedad Española de Neonatología (SEN). Protocolos de Neonatología. 2. ed. España: Asociación Española de Pediatría (AEP). 2003. p: 362-71.

  10. Restrepo N. Manejo de componentes sanguíneos en recién nacidos. Programa de educación continua en pediatría. Sociedad Colombiana de Pediatría. 2013;12(2):59-69.

  11. Parker RI. Transfusion in Critically III Children: Indications, Risks, and Challenges. Crit Care Med. 2014; 42:675-90. doi: 10.1097/CCM.0000000000000176

  12. Kelly AM, Williamson LM. Neonatal transfusion. Early Hum Dev. 2013;89(11):855-60. doi: 10.1016/j.earlhumdev. 2013.08.025.

  13. Whyte RK, Jefferies AL; Canadian Paediatric Society, Fetus and Newborn Committee. Red blood cell transfusion in newborn infants. Paediatr Child Health. 2014;19(4):213-22.

  14. Keir A, Pal S, Trivella M, Lieberman L, Callum J, Shehata N,et al. Adverse effects of red blood cell transfusions in neonates: a systematic review and meta-analysis. Transfusion. 2016;56(11):2773-80. doi:10.1111/trf.13785.

  15. Folarte I, et al. Transfusiones de glóbulos rojos en recién nacidos de muy bajo peso de nacimiento. Rev Chil Pediatr 2014; 85 (3): 298-303. http://dx.doi.org/10.4067/S0370- 41062014000300005

  16. Colombatti R, Sainati L, Trevisanuto D. Anemia and transfusion in the neonate. Semin Fetal Neonatal Med. 2016;21(1):2-9. doi: 10.1016/j.siny.2015.12.001.

  17. Banerjee J, et al. Haemoglobin level at birth is associated with short term outcomes and mortality in preterm infants. BMC Med. 2015;13:16. https://doi.org/10.1186/ s12916-014-0247-6

  18. Bell EF, Strauss RG, Widness JA, Mahoney LT, Mock DM, Seward VJ, et al. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics. 2005;115(6):1685-91.

  19. Mangal R, Meyer EK, Widness JA. Research Opportunities to Improve Neonatal Red Blood Cell Transfusion. Transfus Med Rev 2016;30: 165-73. https://doi.org/10.1016/j. tmrv.2016.06.005

  20. New HV, et al. Guidelines on transfusion for fetuses, neonates and older children. Br J Haematol. 2016;175(5):784- 828. doi: 10.1111/bjh.14233.

  21. Rodrigues L, Barbosa A, Barbosa C, Basílio J, Novello R, Pessôa V, et al. Transfusión de hemocomponentes en niños: ¿qué, cuándo y cómo usar?. Resid. Pediatr. 2015;5(1):14-20.

  22. Comité médico asesor del BloodCenter. Guias de transfusión pediátrica. Wisconsin. Wisconsin BloodCenter; 2015.

  23. Pozo A. Transfusión en neonatología. Rev. Hosp. Mat. Inf. Ramón Sardá. 2009;28(2):86-96

  24. Serrano K, Pambrun C, Levin E, Devine DV. Supernatant reduction of stored gamma-irradiated red blood cells minimizes potentially harmful substances present in transfusion aliquots for neonates. Transfusion. 2017;57:3009-18. doi:10.1111/trf.14270.

  25. Strauss RG. 2008 Emily Cooley Memorial Lecture: lessons learned from pediatric transfusion medicine clinical trials . . . a little child shall lead them. Transfusion. 2009;49(9):1996- 2004. doi: 10.1111/j.1537-2995.2009.02267.x.

  26. Strauss RG. How I transfuse red blood cells and platelets to infants with the anemia and thrombocytopenia of prematurity. Transfusion. 2008;48(2):209-17. doi: 10.1111/j.1537-2995.2007.01592.x.

  27. Mohamed A, Shah PS. Transfusion Associated Necrotizing Enterocolitis: A Meta-analysis of Observational Data. Pediatrics. 2012;219(3):529-763.

  28. Contreras D, Martínez M. Medicina transfusional en el siglo XXI. Rev. Med. Clin. CONDES, 2015; 26(6) 726-743

  29. Kirkley SA, Blumberg N. Use of single donor platelets. Blood Rev. 1994 Sep;8(3):142-7. Review.

  30. Ness PM, Campbell-Lee SA. Single donor versus pooled random donor platelet concentrates. Curr Opin Hematol. 2001;8(6):392–6.

  31. Strauss RG, Wieland MR, Randels MJ, Koerner TA. Feasibility and success of a single-donor red cell program for pediatric elective surgery patients. Transfusion. 1992;32(8):747-9.

  32. Strauss RG, Villhauer PJ, Cordle DG. A method to collect, store and issue multiple aliquots of packed red blood cells for neonatal transfusions. Vox Sang. 1995;68(2):77-81.

  33. Strauss RG. Controversies in the management of the anemia of prematurity using single-donor red blood cell transfusions and/or recombinant human erythropoietin. Transfus Med Rev. 2006;20(1):34-44. https://doi. org/10.1016/j.tmrv.2005.08.003

  34. Neth R, Gallo R, Greaves M, Janka G, editors. Modern trends in human leukemia VI: new results in clinical and biological research including pediatric oncology. Wilsede Joint Meeting on Pediatric Oncology 3, Hamburg, June 21/22, 1984. Berlin: Springer; 1985.

  35. Böck M, Glaser A, Pfosser A, Schleuning M, Heim MU, Mempel W. Storage of single-donor platelet concentrates: metabolic and functional changes. Transfusion. 1993;33(4):311-5

  36. Chambers LA, Kruskall MS, Pacini DG, Donovan LM. Febrile reactions after platelet transfusion: the effect of single versus multiple donors. Transfusion. 1990;30(3):219-21.

  37. Molnar R, et al. Absence of D alloimmunization in D- pediatric oncology patients receiving D-incompatible singledonor platelets. Transfusion. 2002;42(2):177-82. https:// doi.org/10.1046/j.1537-2995.2002.00015.x

  38. Hitzler WE. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products]. Clin Lab. 2014;60(4):S1-39. Review. German.

  39. Dumont LJ, et al. Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results. Transfusion. 2010;50(3):589-99. doi: 10.1111/j.1537- 2995.2009.02460.x. Epub 2009 Nov 19.

  40. Ness P, Braine H, King K, Barrasso C, Kickler T, Fuller A, et al. Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion. 2001 ;41(7):857-61.

  41. Greening DW, et al. Preparation of Platelet Concentrates for Research and Transfusion Purposes. Methods Mol Biol. 2017, 1619:31-42. doi: 10.1007/978-1-4939-7057-53.

  42. Huisman EL, de Silva SU, de Peuter MA. Economic evaluation of pooled solvent/detergent treated plasma versus single donor fresh-frozen plasma in patients receiving plasma transfusions in the United States. Transfus Apher Sci. 2014;51(1):17-24.

  43. Dalal N, Klein LM. Single Donor Vs. Acrodose Platelets in Oncology Patients: A Single Institutional Experience. Biol Blood Marrow Transplant. 2015;21(2):S247–8.

  44. Riga A, et al. Blood donors--Serious adverse reactions (SAR) 2010-2014 EFS Châteauroux, France. Transfus Clin Biol. 2015;22(2):62-5. https://doi.org/10.1016/j. tracli.2015.04.002

  45. Tinmouth AT, et al. Platelet immunopathology and therapy: a Canadian Blood Services Research and Development Symposium. Transfus Med Rev. 2006;20(4):294-314. https:// doi.org/10.1016/j.tmrv.2006.05.008

  46. Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DB, Skacel P, Barbara JA. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ. 1999;319(7201):16-9.




2020     |     www.medigraphic.com